退行性二尖瓣病变八旬高龄患者二尖瓣手术后的生存预测因素:八旬高龄患者二尖瓣手术研究
该多中心回顾性研究纳入3个中心247例因退行性病变接受二尖瓣手术的八旬高龄患者,比较二尖瓣修复与置换的生存及预测因素。修复组30天死亡率低于置换组(4.7% vs 18.6%,P<.01),长期生存也优于置换组(P=.0005)。二尖瓣置换和主动脉内球囊反搏使用是长期生存的独立预测因素,逻辑欧洲心脏手术风险评估系统未能预测早期死亡。
要点
- 八旬高龄患者二尖瓣修复30天死亡率为4.7%,低于置换组的18.6%(P<.01)。
- 二尖瓣置换是短期复合结局(OR 7.7)和长期生存(HR 1.88)的独立预测因素。
- 逻辑欧洲心脏手术风险评估系统在本队列中预测早期死亡能力不佳(AUC 0.57%)。
核心结论
- 在八旬高龄患者中,退行性二尖瓣病变行二尖瓣修复与良好生存相关,仍是金标准,而二尖瓣置换仍与显著死亡率相关。
- 逻辑欧洲心脏手术风险评估系统未能预测本队列患者的早期死亡。
- 需要更大规模国际多中心注册研究以优化此类高危亚组的决策过程。
研究设计与样本
- 多中心回顾性研究,汇集英国3个高容量专科中心的数据。
- 共纳入247例因退行性病变接受二尖瓣手术的八旬高龄患者,中位随访2.9年(最短0年,最长14年)。
- 采用多变量逻辑回归模型分析30天死亡、急性肾损伤和脑血管意外的短期复合结局,Cox回归分析晚期死亡,Kaplan-Meier曲线分析长期生存,受试者工作特征曲线分析逻辑欧洲心脏手术风险评估系统的预测效能。
主要发现
- 150例(60.7%)行二尖瓣修复,97例(39.3%)行二尖瓣置换。
- 再次心脏手术在修复组6例(4%)vs 置换组11例(11.3%)(P=.04),术前心房颤动修复组79例(52.6%)vs 置换组34例(35.1%)(P<.01),其余术前特征两组无显著差异。
- 逻辑欧洲心脏手术风险评估系统估计的手术风险修复组为10.2±11.8 vs 置换组13.7±15.2(P=.07),体外循环和主动脉阻断时间两组无差异。
- 全队列30天死亡率为13.8%(修复组4.7% vs 置换组18.6%;P<.01);术后脑血管意外(2% vs 3.1%;P=.9)、需透析的急性肾损伤(6.7% vs 13.4%;P=.12)、浅表或深部胸骨伤口感染(分别为10% vs 16.5%,P=.17;2% vs 3.1%,P=.67)两组无差异。
- 短期复合结局的多变量回归模型包括既往心脏手术(OR 4.47;95%CI 1.37-17.46;P=.02)、主动脉内球囊反搏使用(OR 4.77;95%CI 1.67-15.79;P<.01)和二尖瓣置换(OR 7.7;95%CI 4.04-14.9;P<.01)。
临床怎么用
- 作者认为,在八旬高龄患者中,退行性二尖瓣病变行二尖瓣修复与良好生存相关,仍是金标准。
- 作者指出,二尖瓣置换仍与显著死亡率相关,逻辑欧洲心脏手术风险评估系统未能预测本队列早期死亡,需要更大规模国际多中心注册研究以优化决策。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: An increasing number of octogenarians are referred to undergo mitral valve surgery for degenerative disease, and percutaneous approaches are being increasingly used in this subgroup of patients. We sought to determine the survival and its predictors after Mitral Valve Surgery in Octogenarians (MiSO) in a multicenter UK study of high-volume specialized centers. METHODS: Pooled data from 3 centers were collected retrospectively. To identify the predictors of short-term composite outcome of 30 days mortality, acute kidney injury, and cerebrovascular accident, a multivariable logistic regression model was developed. Multiple Cox regression analysis was performed for late mortality. Kaplan-Meier curves were generated for long-term survival in various subsets of patients. Receiver operating characteristic analysis was done to determine the predictive power of the logistic European System for Cardiac Operative Risk Evaluation. RESULTS: A total of 247 patients were included in the study. The median follow-up was 2.9 years (minimum 0, maximum 14 years). A total of 150 patients (60.7%) underwent mitral valve repair, and 97 patients (39.3%) underwent mitral valve replacement. Apart from redo cardiac surgery (mitral valve repair 6 [4%] vs mitral valve replacement 11 [11.3%], P = .04) and preoperative atrial fibrillation (mitral valve repair 79 [52.6%] vs mitral valve replacement 34 [35.1%], P < .01), there was no significant difference in terms of any other preoperative characteristics between the 2 groups. Patient operative risk, as estimated by logistic European System for Cardiac Operative Risk Evaluation, was lower in the mitral valve repair group (10.2 ± 11.8 vs 13.7 ± 15.2 in mitral valve replacement; P = .07). No difference was found between groups for duration of cardiopulmonary bypass and aortic crossclamp times. The 30-day mortality for the whole cohort was 13.8% (mitral valve repair 4.7% vs mitral valve replacement 18.6%; P < .01). No differences were found in terms of postoperative cerebrovascular accident (2% vs 3.1%; P = .9), acute kidney injury requiring dialysis (6.7% vs 13.4%; P = .12), and superficial or deep sternal wound infection (10% vs 16.5%, P = .17; 2% vs 3.1%, P = .67, respectively). The final multiple regression model for short-term composite outcome included previous cardiac surgery (odds ratio [OR], 4.47; 95% confidence interval [CI], 1.37-17.46; P = .02), intra-aortic balloon pump use (OR, 4.77; 95% CI, 1.67-15.79; P < .01), and mitral valve replacement (OR, 7.7; 95% CI, 4.04-14.9; P < .01). Overall survival for the entire cohort at 1, 5, and 10 years was 82.4%, 63.7%, and 45.5% (mitral valve repair vs mitral valve replacement: 89.9% vs 70.7% at 1 year, 69.6% vs 54% at 5 years, and 51.8% vs 35.5% at 10 years; P = .0005). Cox proportional hazard model results showed mitral valve replacement (hazard ratio, 1.88; 95% CI, 1.22-2.89; P < .01) and intra-aortic balloon pump use (hazard ratio, 2.54; 95% CI, 1.26-5.13; P < .01) to be independent predictor factors affecting long-term survival. Logistic European System for Cardiac Operative Risk Evaluation did not perform well in predicting early mortality (area under the curve, 0.57%). CONCLUSIONS: In octogenarians, mitral valve repair for degenerative disease is associated with good survival and remains the gold standard, whereas mitral valve replacement is still associated with significant mortality. Logistic European System for Cardiac Operative Risk Evaluation was unable to predict early mortality in our cohort of patients. Larger international multicenter registries are required to optimize the decision-making process in such a high-risk subgroup.
引用
- Chivasso P, Bruno VD, Farid S, et al. Predictors of survival in octogenarians after mitral valve surgery for degenerative disease: The Mitral Surgery in Octogenarians study. J Thorac Cardiovasc Surg. 2017. PMID: 29249501. doi:10.1016/j.jtcvs.2017.11.027
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。